Preventing pandemics. Winter 12By Dr Nathaniel Hentz Over the years, influenza has taken the lives of millions. While vaccines are helping to reduce the damage caused by the virus, there is still a major capacity shortfall. Could access to ...
|
Cell Migration: probing cell movement with smarter tools. Winter 12By Dr John Comley Cell migration comprises the movement of cells from one location to another in response to events, biological signals or environmental cues. Cell migration plays a critical role in numero...
|
Epigenetics: are we hitting the mark? Fall 12By Dr Andrew J. Pope and Dr Amy M. Quinn During the last few years, advances in the understanding of epigenetic processes have led to an explosion in interest in this area as a potential source of new targets for the discovery o...
|
Nanobioscience: the future of personalised medicine. Fall 12By Abhishek Gottipati, Joseph M. Sanders and Dr Scott A. Tenenbaum Nanotechnology has been more than a buzz word in the business world for a long time now and has been striding ahead, living up to the hype.
|
In vivo imaging in drug development GAMMA SCINTIGRAPHY. Summer 12By Dr Alyson Connor Gamma scintigraphy is a non-invasive technique with applications in the development of drug products and the assessment of pharmacodynamic effects in humans. It enables the assessment of ...
|
Editing the Human Genome: role in functional genomics and translational medicine. Summer 12By Dr Chris Torrance and Eric Rhodes It is now readily accepted that we are in a post genomic era. With the steady flow of genomic information available to researchers worldwide, the focus turns to ways to analyse this infor...
|
Pharmaceutical & biomedical research likely to use $1 billion worth of microfluidics devices by 2016. Summer 12By Frédéric Breussin The proliferation of lower cost genomics tools, and the maturing of microfluidics lab equipment into more robust tools that better interface with established research flows, could drive m...
|
Small Scale Benchtop Automation: broadening the adoption of lab automation. Winter 11By Dr John Comley Driven by the need to enable technically challenging or repetitive processes, many labs in drug discovery that were not previously adopters of laboratory automation are being increasingly...
|
|
|
